Understanding how inflammation affects heart and metabolic health
Official title: Cardiometabolic Health and Inflammatory Resolution (Kardiometabol hälsa Och Inflammatorisk Resolution)
Run by Göteborg University · NCT04256330 · Data updated 2026-11-12
This study looks at how inflammation affects heart and metabolic health in people of different weights to see how it impacts their overall health.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Göteborg University Academic / other |
| Drugs / interventions | methotrexate |
| Locations | 1 site (Gothenburg, Västra Götaland County) |
| Status | Recruiting |
| Started | January 23, 2020 |
| Main results expected | December 31, 2026 |
| Study ends | September 1, 2027 |
| Registry record updated | May 8, 2025 |
| Trial ID | NCT04256330 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are volunteers aged 18 and older with a BMI greater than 18.5 kg/m2.
✕Probably not a fit
Patients with chronic inflammation, those on immunosuppressive drugs, or individuals with increased bleeding tendencies may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the relationship between inflammatory resolution and cardiometabolic health in individuals with varying body mass indices (BMIs). Participants will include lean, overweight, and obese volunteers who meet specific eligibility criteria. The study will assess how inflammation impacts health outcomes in these groups, focusing on their metabolic profiles and cardiovascular health. Data will be collected through blood draws and health assessments to analyze the effects of inflammation on cardiometabolic conditions.
Why it matters
Potential benefit: If successful, this study could provide insights into how managing inflammation may improve heart and metabolic health in diverse populations.
How similar studies have gone: While this study explores a specific aspect of inflammation and cardiometabolic health, similar studies have shown promising results in understanding the role of inflammation in various health conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Informed signed consent has been obtained from the volunteer. * The volunteer has a BMI greater than 18.5 kg/m2 Exclusion Criteria: * The study staff contacting a potential participant perceives that the individual has difficulty understanding the information. * An MD determines that the individual is on too many medications to participate * The individual takes a medication that is approved by the MD, but he/she is not willing or not able to wait with any potential morning medication until after their fasted blood-draw. * The individual is younger than 18 years (relevant for the FAINT-1 and FAINT-2 cohorts) * The individual states that they have increased bleeding tendency or are using anti-coagulant (blood thinning) medication. * The individual has some form of chronic inflammation. * The individual regularly uses medication that affects inflammatory resolution (e.g., low-dose aspirin). * The individual uses immunosuppressive drugs (eg, methotrexate). * The individual regularly consumes fish oils (omega 3). * The individual has significant gastrointestinal problems. * The individual smokes or uses chewing tobacco. * The individual has been drinking alcohol two days before the study visit. * The individual has tattoos or body piercings on the forearms and / or the stomach that can affect the examination. * The individual does not follow instructions given in the research study.
Where it's running
-
Gothenburg university
Gothenburg, Västra Götaland County, Sweden Recruiting
Study contacts
- Study coordinator: Emma Börgeson, PhD
- Email: emma.borgeson@wlab.gu.se
- Phone: +46313423833
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Breathlessness patterns in adults with cancer, COPD, or heart failure using brain fMRI and immersive virtual reality
This project will try to use brain fMRI combined with immersive virtual reality to identify patterns of persistent breathlessness in adults with COPD, heart failure, or cancer and in healthy volunteers.
-
Effects of different screen sizes on stress measurement
This study tests how different screen sizes affect people's stress levels as measured by a simple scale and looks at how these responses change over a week.
-
Quality of life during adjuvant immunotherapy for locally advanced non-small cell lung cancer
This study looks at how patients feel and cope during a year of immunotherapy after chemoradiotherapy for locally advanced non-small cell lung cancer.
-
Health effects of ultra-processed foods on appetite and cardiometabolic health
This study tests whether a high ultra-processed food diet affects appetite and cardiometabolic health compared with a nutrient-matched low ultra-processed diet in adults who keep their weight stable.
-
Life-sustaining care decisions in critically ill children
This study looks at how decisions about withholding or withdrawing life-sustaining treatments are made for critically ill children in intensive care.
-
Short-term effects of ultra-processed foods on metabolism
This project will test whether a short-term diet high in ultra-processed foods versus a nutrient- and energy-matched low-UPF diet changes appetite and how much adults with BMI 18.5–30 eat.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.